DiaSorin Gets FDA Clearance for Test to Differentiate Bacterial, Viral Infections
The Liaison MeMed BV assay can help determine whether a patient's infection is caused by a bacterial or viral pathogen.
In Brief This Week: Thermo Fisher Scientific, T2 Biosystems, MeMed, More
News items for the week of June 6, 2022.
MeMed Closes $93M Private Financing Round
The company said it will use the funds to scale manufacturing and accelerate commercialization of its MeMed BV and MeMed COVID-19 Severity tests.
DiaSorin, MeMed Obtain CE Mark for High-Throughput Immune-Response Assay
The Liaison MeMed BV high-throughput test uses host-response data to enable physicians to differentiate between bacterial and viral infections.
Roche, Thermo Fisher Scientific, DiaSorin, BioMérieux, and Others Obtain FDA Clearances in September
Roche obtained clearance for a modification, which decreases inference to biotin, to its cleared Elecsys Troponin T Gen 5 immunoassay for myocardial infarction.